| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |